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Identification of functional exonic
splicing enhancer motifs recognized
by individual SR proteins
Hong-Xiang Liu, Michael Zhang, and Adrian R. Krainer1
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724-2208 USA
Using an in vitro randomization and functional selection procedure, we have identified three novel classes of
exonic splicing enhancers (ESEs) recognized by human SF2/ASF, SRp40, and SRp55, respectively. These ESEs
are functional in splicing and are highly specific. For SF2/ASF and SRp55, in most cases, only the cognate SR
protein can efficiently recognize an ESE and activate splicing. In contrast, the SRp40-selected ESEs can
function with either SRp40 or SRp55, but not with SF2/ASF. UV cross-linking/competition and
immunoprecipitation experiments showed that SR proteins recognize their cognate ESEs in nuclear extract by
direct and specific binding. A motif search algorithm was used to derive consensus sequences for ESEs
recognized by these SR proteins. Each SR protein yielded a distinct 5- to 7-nucleotide degenerate consensus.
These three consensus sequences occur at higher frequencies in exons than in introns and may thus help
define exon–intron boundaries. They occur in clusters within regions corresponding to naturally occurring,
mapped ESEs. We conclude that a remarkably diverse set of sequences can function as ESEs. The degeneracy
of these motifs is consistent with the fact that exonic enhancers evolved within extremely diverse protein
coding sequences and are recognized by a small number of SR proteins that bind RNA with limited sequence
specificity.
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Pre-mRNA splicing consists of two trans-esterification
reactions, which occur in a large RNA–protein complex
termed the spliceosome. This high-fidelity process re-
quires precise recognition of the intron–exon borders by
the spliceosome. The poorly conserved metazoan splice
sites and branch site do not provide sufficient informa-
tion for this recognition. Additional intron and exon se-
quences are often necessary for efficient and/or accurate
splicing of many higher eukaryotic pre-mRNAs. The
positive exon cis-acting elements, known as exonic
splicing enhancers (ESEs), are often, though not always,
found in a purine-rich context. A well-studied example is
the ESE in the alternative exon M2 of the mouse IgM
gene. This 73-nucleotide ESE is essential for splicing of
the preceding intron between exons M1 and M2. The M2
ESE can also stimulate splicing of a heterologous regu-
lated intron of the Drosophila doublesex (dsx) gene. En-
hancer activity in the context of the IgM pre-mRNA
could also be obtained by insertion of certain natural or
synthetic purine-rich sequences in place of the natural
ESE. However, deletion of the purine-rich sequences
within the M2 ESE did not abolish its activity com-
pletely (Watakabe et al. 1993; Tanaka et al. 1994). In
agreement with this finding, SELEX experiments re-
vealed that certain nonpurine-rich sequences can also
function as enhancers (Tian and Kole 1995; Coulter et al.
1997). Most natural ESEs have been identified in tissue-
specific or developmentally regulated exons, which typi-
cally have weak splice sites and require the ESE for exon
inclusion. In some cases, ESEs are specifically recognized
by one or more SR proteins (Lavigueur et al. 1993; Sun et
al. 1993; Tian and Maniatis 1993, 1994; Ramchatesingh
et al. 1995; Gontarek and Derse 1996). In turn, SR pro-
teins are expressed at different levels in different tissues,
and their expression also appears to be regulated by al-
ternative splicing (Jumaa et al. 1997; for review, see Ca´-
ceres and Krainer 1997).
The SR proteins are a family of highly conserved ser-
ine/arginine-rich RNA-binding proteins. They are essen-
tial splicing factors (Krainer et al. 1990b, 1991; Ge et al.
1991; Zahler et al. 1992) and also regulate the selection
of alternative splice sites in a concentration-dependent
manner (Ge and Manley 1990; Krainer et al. 1990a;
Zahler et al. 1993a), in part by antagonizing the activity
of hnRNP A1 (Mayeda and Krainer 1992). The SR pro-
teins act very early in spliceosome assembly (Krainer et
al. 1990a; Fu and Maniatis 1992; Staknis and Reed 1994).
They promote the binding of U1 snRNP to the 58 splice
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site (Eperon et al. 1993; Wu and Maniatis 1993; Kohtz et
al. 1994; Staknis and Reed 1994; Zahler and Roth 1995)
and of U2AF65 to the 38 splice site (Wu and Maniatis
1993), apparently by interacting with U1 70K and
U2AF35, respectively. These observations have led to the
hypothesis that SR proteins bound to ESEs recruit splic-
ing factors to bind to the splice sites of adjacent introns
(Wu and Maniatis 1993; Staknis and Reed 1994).
Nine human SR proteins are presently known: SF2/
ASF, SC35, SRp20, SRp40, SRp75, SRp55, 9G8, SRp30c,
and the somewhat more divergent p54. These proteins
are closely related in primary structure and share the
ability to complement splicing in a HeLa cell S100 ex-
tract (Ge et al. 1991; Krainer et al. 1991; Fu et al. 1992;
Zahler et al. 1992, 1993b; Cavaloc et al. 1994; Screaton et
al. 1995; Zhang and Wu 1996). SR proteins appear to have
partially redundant functions, such that several different
members of the family can complement an S100 extract
to splice the same pre-mRNA, and/or stimulate use of
the same alternative 58 splice sites in vitro or in vivo.
However, substrate-specific differences in general splic-
ing, enhancer-dependent splicing, or alternative splicing
mediated by different SR proteins have also been re-
ported (Fu 1993; Sun et al. 1993; Zahler et al. 1993a;
Ca´ceres et al. 1994; Wang and Manley 1995; Chandler et
al. 1997). Drosophila SRp55/B52 has been shown to be
essential for development (Ring and Lis 1994; Peng and
Mount 1995), and at least one copy of the chicken SF2/
ASF gene is required for survival of a B-lymphocyte cell
line (Wang et al. 1996), demonstrating that at least some
functions important for development or cell viability are
uniquely carried out by single SR proteins in vivo. Indi-
vidual SR proteins also differ in their subnuclear local-
ization signals and in their ability to shuttle between the
nucleus and the cytoplasm (Ca´ceres et al. 1997, 1998).
Finally, individual SR proteins exhibit striking phyloge-
netic sequence conservation of all their constituent do-
mains (Birney et al. 1993). Taken together, these obser-
vations demonstrate that individual SR proteins have
some unique, specific functions.
Although SR proteins have been clearly implicated in
ESE recognition and function, predictive rules for the
recognition of ESEs by different SR proteins have not
been derived. In this study, we sought to determine the
specificity of individual SR proteins in ESE recognition
by performing a randomization and selection procedure
under splicing conditions.
Results
Identification of SR protein target sequences
from a random pool under splicing conditions
To find specific target sequences recognized by indi-
vidual SR proteins under splicing conditions, a procedure
based on SELEX (Tuerk and Gold 1990) was utilized im-
posing a selection for splicing (Tian and Kole 1995;
Coulter et al. 1997), rather than for binding (Heinrichs
and Baker 1995; Tacke and Manley 1995; Shi et al. 1997;
Tacke et al. 1997). We modified the procedure further by
carrying out the splicing reactions in the presence of a
single, recombinant SR protein, which was used to
complement HeLa extracts deficient in SR proteins—
either an S100 extract or an SR protein-depleted nuclear
extract. We performed the selection for ESEs in the con-
text of a well-characterized IgM minigene transcript,
comprising the last intron flanked by the M1 and M2
membrane isoform-specific exons. A prototypical ESE
was previously mapped to a 73 nucleotide fragment of
exon M2 (Watakabe et al. 1993). This ESE was found to
be essential for IgM pre-mRNA splicing in nuclear or
S100 extract (Watakabe et al. 1993; H.-X. Liu et al., un-
publ.). The scheme for the randomization and selection
procedure is outlined in Figure 1A (for details, see Mate-
rials and Methods). First, the natural ESE in the M2 exon
(Fig. 1B) was replaced by 20 nucleotides of random se-
quence. A library of pre-mRNAs representing 1.2 × 1010
different sequences was spliced in S100 extract comple-
mented by either recombinant SF2/ASF, SRp40, or
SRp55 (Fig. 2). As a control, equivalent samples from the
same library were spliced in nuclear extract, which con-
tains all the SR proteins. A significant proportion of the
pre-mRNAs from the initial pool contained sequences
that functioned as enhancers in the nuclear extract, thus
resulting in easily detectable levels of spliced mRNA
(lanes 1,4,7). In contrast, no splicing could be detected by
this direct assay in the S100 extract alone (lanes 2,5,8), or
in reactions with S100 extract plus one of the SR pro-
teins (lanes 3,6,9). Nevertheless, we assumed that a
small proportion of the initial randomized sequences
could function as enhancers in the presence of single SR
proteins.
The presumptive spliced mRNAs, now carrying func-
tional ESEs, were recovered from the expected region of
denaturing polyacrylamide gels. For each S100 comple-
mentation reaction, the randomized region of exon M2
of the spliced mRNAs was then amplified by RT-PCR
and reassembled into a new pool of pre-mRNAs for fur-
ther selection. The amplification was carried out by
overlap extension with two different upstream primers,
to ensure that only spliced mRNAs were amplified (Fig.
1). PCR amplification confirmed the presence of spliced
mRNAs after the initial round of selection. Two addi-
tional rounds of selection were carried out in SR protein-
depleted nuclear extract (Blencowe et al. 1994) comple-
mented with individual SR proteins, to mimic the con-
ditions of nuclear extract, to minimize possible biases
specific to the S100 extract, and to select the most effi-
cient ESEs.
After three rounds of selection, the spliced mRNAs
were amplified by RT-PCR, subcloned and sequenced.
Twenty-four or more independent sequences obtained
with each SR protein were analyzed to determine a con-
sensus sequence, using the program Gibbs sampler
(Lawrence et al. 1993). The defined motifs were used to
generate a score matrix, according to the frequency of
each nucleotide at each position. These score matrices
were used to search the high-score motifs in each winner
sequence. Small portions of the constant flanking re-
gions (18 nucleotides of the 58 region and 20 nucleotides
SR protein-specific exonic splicing enhancers
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of the 38 region) were included during the search. The
resulting alignments of sequences selected with SF2/
ASF, SRp40, or SRp55 are shown in Figures 3A, 4, and 5,
respectively. As a control, 30 sequences from the initial
random RNA pool are shown in Figure 3B.
The consensus sequences derived for each of the three
SR proteins tested differed in both length and sequence.
Each of the consensus sequences is relatively degenerate,
and not all of the individual selected sequences match
the consensus at every position. However, many of the
individual sequences have more than one good match to
the consensus, allowing for one or two mismatches.
The SF2/ASF winners gave the consensus sequence
SRSASGA (S represents G or C, R represents purine),
which only in some cases corresponds to a purine-rich
motif. The content of U residues in the SF2/ASF winner
pool was 16%, which represents a significant reduction
from the 21% of U residues found in the initial random
pool. This reduction can be accounted for by the absence
of U residues from the consensus motif. The content of
C residues increased by 4%. The frequency of A and G
did not vary significantly upon selection (Fig. 3A,B). SF2/
ASF was shown previously to recognize purine-rich se-
quences in SELEX procedures based on binding; the re-
ported sequences, RGAAGAAC and AGGACRRAGC
(Tacke and Manley 1995), are significantly different
from, and simpler than, the consensus motif we found.
Similar experiments, performed independently in our
lab, revealed a different purine-rich consensus sequence,
GARGAGC (A. Hanamura, I. Watakabe, and A.R.
Krainer, unpubl.). In the present study, only 13 of 28
winners have uninterrupted purine-rich motifs longer
than 5 nucleotides, indicating that SF2/ASF can produc-
tively recognize a far broader range of sequences. Indeed,
the overall purine composition of the SF2/ASF-selected
pool did not change significantly from that of the initial
random pool.
The consensus for the SRp40-selected sequences is
ACDGS (D represents residues other than C; S repre-
sents G or C). This consensus is also very different from
that previously determined as an optimal RNA-binding
site for SRp40, TGGGAGCRGTYRGCTCGY (Tacke et
al. 1997). The content of G residues in the SRp40 winner
RNA pool decreased from 39% in the initial random pool
Figure 2. Splicing of the pre-mRNA pool prior to selection.
Radiolabeled pre-mRNA (20 fmoles) from the unselected initial
pool was incubated under splicing conditions in nuclear extract
(lanes 1,4,7), in S100 extract only (lanes 2,5,8), or in S100 extract
complemented with the indicated SR protein (lanes 3,6,9). The
RNAs were analyzed by denaturing PAGE (12% polyacryl-
amide) and autoradiography. The structures and mobilities of
the precursor, intermediates, and products of splicing (Wata-
kabe et al. 1993) are shown next to each autoradiograph.
Figure 1. Procedure for randomization and selection of ESEs.
(A) The natural ESE in mouse IgM exon M2 was replaced by a
20-nucleotide segment of random sequence, and a library of
pre-mRNAs was constructed by overlap–extension PCR and
in vitro transcription. A sample of this pool, representing
∼1.2 × 1010 pre-mRNA molecules was then spliced in vitro by
complementation of an S100 extract with individual recombi-
nant SR proteins. The pool of spliced mRNA products was gel
purified, and the sequences corresponding to the ESE region
were rebuilt into pre-mRNA template molecules for a new
round of selection, or subcloned and sequenced. The sequences
were analyzed by a motif-search algorithm to identify common
patterns. (B) Sequence of the M2 exon of the mouse IgM gene.
The sequence of the previously mapped ESE is shown in upper-
case.
Liu et al.
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to 34%. The content of C residues increased by 5%. The
frequency of A and U did not change significantly (Figs.
4 and 3B). The consensus motif for the SRp40 winners is
relatively short but has a sufficient information content,
such that, for example, it does not occur by chance in
most of the RNAs sampled from the initial random pool.
Winners SRp40-1, SRp40-2, SRp40-3, and SRp40-4, for
example, are clearly not derived from a single founder
sequence by accumulated mutations during PCR. How-
ever, they all share the sequence ACGGC, which
matches the consensus, and is the only common se-
quence among these winners. Similar sequence relation-
ships are seen among winners SRp40-5, SRp40-6, SRp40-
7; SRp40-8, SRp40-9, SRp40-10; SRp40-11, SRp40-12;
SRp40-13, SRp40-14; and SRp40-15, SRp40-16.
The SRp55 winners yielded the consensus sequence
USCGKM (S represents G or C; K represents U or G; M
represents A or C). The C residue content in the SRp55
winner pool increased significantly, from 19% in the
starting pool to 26%. The content of G and U residues
decreased by 5% and 4%, respectively (Figs. 5 and 3B).
B52, which appears to be the Drosophila ortholog of hu-
man SRp55, was reported to have GRUCAACCNGGC
GACNG as the optimal binding site (Shi et al. 1997). In
that report, it was also suggested that a hairpin structure
was required for efficient B52 binding. In contrast, we did
not observe common secondary structure elements in
our human SRp55 winner sequences.
The same sequence analysis programs were used to
search the clones from the initial random pool, but no
stable pattern was found. Each set of aligned winner se-
quences was used to create a score matrix that takes into
account the overall nucleotide composition of the corre-
sponding winner pool (see Materials and Methods). The
scores of the SF2/ASF winner sequences ranged from
1.34 to 3.74, with a mean of 2.7; those of the SRp40
winner pool ranged from 0.33 to 1.68, with a mean of 1.2;
those of the SRp55 winner pool ranged from 2.37 to 6.17,
with a mean of 4.64. The sequence-scores for each SR
protein correlated with the observed splicing efficien-
cies; however, sequence-scores for different SR proteins
cannot be compared. The score matrices were then used
Figure 4. Sequence alignment of SRp40-specific ESEs. D = A,
G, or U. For details, see Fig. 3 legend.
Figure 5. Sequence alignment of SRp55-specific ESEs. K = U or
G; M = A or C. For details, see Fig. 3 legend.
Figure 3. Sequence alignment of SF2/ASF-
specific ESEs (A) and sequences from the ini-
tial random pool (B). A consensus motif was
identified as described in the text. The se-
quences are aligned on the basis of the best fit
to the consensus within each sequence.
Nucleotides in the boxed alignment that
match the consensus position are shown
white on black; mismatched nucleotides are
not shaded. Underlined nucleotides are from
the constant region flanking the randomized
segment. The nucleotide composition of the
randomized segment in the selected pool is
provided in the lower left corner. S = G or C;
R = A or G. Clones indicated in parentheses
were selected for further characterization.
SR protein-specific exonic splicing enhancers
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to search the clones from all three of the winner pools
and the initial random pool. The mean score of the cor-
responding SR protein-selected winner pool was always
higher than that of the other three pools (data not
shown). In particular, among the 30 sequences from the
initial pool, only 3 had scores above the mean for the
SF2/ASF-selected pool, 5 had scores above the mean for
the SRp40-selected pool, and none had scores above the
mean for the SRp55-selected pool.
The SELEX winner sequences function
as bona fide ESEs
To investigate the functional importance of the winner
sequences, several winners were randomly chosen from
the winner pools of each SR protein. Their ability to
function as enhancers was tested by splicing the corre-
sponding pre-mRNAs in HeLa nuclear extract or in S100
extract plus specific SR proteins (Fig. 6).
All the SF2/ASF-selected sequences promoted effi-
cient splicing in nuclear extract (Fig. 6A, lanes 1,4,7,10,
13,16,19,22), compared to an enhancerless construct,
which is essentially inactive (Watakabe et al. 1993; data
not shown), indicating that the selected sequences could
function as true ESEs. In each case, they promoted more
efficient splicing in nuclear extract than any of several
sampled round 0 sequences (data not shown). Further-
more, these ESE sequences promoted splicing in S100
extract plus recombinant SF2/ASF, albeit with variable
efficiencies (Fig. 6A, lanes 3,6,9,12,15,18,21,24), but not
in S100 extract only (Fig. 6A, lanes 2,5,8,11,14,17,20,23).
The splicing efficiency in S100 extract plus SF2/ASF was
lower than that of the nuclear extract. Winner sequences
comprising either purine-rich (B1, B3, B4, B5, and B7) or
nonpurine-rich motifs (B2, B6, and B8) resulted in a com-
parable range of splicing efficiencies.
Similar results were obtained in splicing assays with
the SRp40 winners. All of the 7 winners tested spliced
with somewhat variable efficiencies in nuclear extract
(Fig. 6B, lanes 1,4,7,10,13,16,19) and in S100 extract plus
recombinant SRp40 (Fig. 6B, lanes 3,6,9,12,15,18,21), but
not in S100 extract only (Fig. 6B, lanes 2,5,8,11,14,17,20).
The splicing efficiency of the SRp40 winners in nuclear
extract was lower on average than that of the SF2/ASF
winners (Fig. 6A,B). In S100 extract alone, several of the
pre-mRNAs were extensively degraded (Fig. 6B, con-
structs E1, E2, E4, and E7). This observation is consistent
with the notion that SR proteins are involved in the as-
sembly of a commitment complex, such that substrates
that are not productively assembled into commitment
Figure 6. The selected sequences are functional SR protein-de-
pendent ESEs. (A) In vitro splicing of pre-mRNAs containing the
SF2/ASF-selected winner sequences in HeLa nuclear extract
(lanes 1,4,7,10,13,16,19,22), S100 extract alone (lanes 2,5,8,11,14,
17,20,23), or S100 complemented by 20 pmoles of recombinant
SF2/ASF (lanes 3,6,9,12,15,18,21,24). (B) Splicing of SRp40-se-
lected winner sequences in nuclear extract (lanes 1,4,7,10,
13,16,19), S100 extract alone (lanes 2,5,8,11,14,17,20), or S100
extract complemented by 20 pmoles of recombinant SRp40 (lanes
3,6,9,12,15,18,21). (C) Splicing of SRp55-selected winner se-
quences in nuclear extract (lanes 1,5,9,13,17,21,25,29), S100 ex-
tract alone (lanes 2,6,10,14,18,22,26,30), or in S100 extract complemented by 10 pmoles SRp55 (lanes 3,7,11,15,19,23,27,31) or by 20
pmoles of SRp55 (lanes 4,8,12,16,20,24,28,32). The RNAs were analyzed by denaturing PAGE (5.5% polyacrylamide) and autoradiog-
raphy. The structures and mobilities of the precursor, intermediates, and products of splicing (Watakabe et al. 1993) are shown next
to each autoradiograph.
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complexes and pre-spliceosomes are generally more sus-
ceptible to degradation by non-specific nucleases present
in some batches of extract.
The eight tested SRp55 winners all spliced to variable
extents in nuclear extract (Fig. 6C, lanes 1,5,9,13,17,21,
25,29) and in S100 extract plus SRp55 (Fig. 6C, lanes
4,8,12,16,20,24,28,32), but not in S100 extract only (Fig.
6C, lanes 2,6,10,14,18,22,26,30). Interestingly, four of
the eight SRp55 winners tested spliced more efficiently
in S100 extract plus SRp55 than in nuclear extract alone
(Fig. 6C, C1, C4, C6, and C7), suggesting that SRp55 is
the only SR protein required for effective recognition of
these winner sequences. The higher splicing efficiency of
C1, C4, C6, and C7 pre-mRNAs in S100 compared to
nuclear extract cannot be accounted for by their in-
creased stability, since the remaining winners, C2, C3,
C5, and C7, were also greatly stabilized in S100 extract
plus SRp55, but their splicing efficiencies were lower
than in the nuclear extract.
We tested whether the short consensus motifs are suf-
ficient to activate splicing. This was done by replacing
sequences within template A13 by the short consensus
motifs from the B1, B2, C4, or E7 winners (Figs. 3–5) and
then testing the splicing activity of the corresponding
pre-mRNAs. A13 was isolated from the initial random
pool and had very low splicing activity in nuclear extract
and no splicing activity in S100 extract complemented
with any of the three SR proteins tested. Insertion of one
copy of the consensus motifs was sufficient to activate
splicing of the modified A13 pre-mRNA in S100 extract
plus the cognate SR protein, although the splicing effi-
ciencies were very low (data not shown). The low effi-
ciency suggests that the sequence context surrounding
the conserved motifs is also important for splicing, con-
sistent with the observation that several of the winner
sequences contain more than one match to the consen-
sus. We also made and tested a number of clustered point
mutations in several of the ESEs selected by each SR
protein. We were unable to inactivate ESE function ei-
ther by mutations in the best match to the consensus
motif or by mutations on either side of the motif (data
not shown). This unexpected observation suggests that
each of the selected sequences has a high level of internal
functional redundancy, which is probably necessary to
allow efficient splicing.
SR protein specificity of the selected ESEs
The fact that each SR protein selected ESEs that fit a
different consensus sequence suggests that SR proteins
recognize the synthetic ESEs in a sequence-specific man-
ner. On the other hand, the observation that most of the
winner sequences promoted more efficient splicing in
nuclear extract than in the S100 complementation reac-
tions suggests that SR proteins may function coopera-
tively. We examined these possibilities by testing the
effect of different SR proteins on splicing of pre-mRNAs
with each type of winner. These experiments were per-
formed in S100 extract complemented with individual
SR proteins or with pairwise combinations thereof.
Strikingly, the three kinds of SR protein winner se-
quences showed very different specificities (Table 1).
The SRp40-selected winner sequences failed to splice
in S100 extract plus SF2/ASF (Fig. 7A, lanes 1,4,7,10,13,
16,19), even at higher concentrations of SF2/ASF (data
not shown). However, they did splice in S100 extract
plus SRp55 (Fig. 7B, lanes 1,4,7,10,13,16). Adding two SR
proteins together did not significantly increase the splic-
ing efficiency, although additive effects were observed
with two of the winners, E4 and E6, using SRp40 and
SRp55 (Fig. 7A,B).
The SF2/ASF-selected winner sequences gave a differ-
ent result. The B2 winner spliced poorly in the presence
of S100 extract and SRp55, whereas the remaining win-
ners, B1, B3, B4, B5, B6, and B7, failed to splice under
these conditions (Table 1). SRp40 did not activate splic-
ing of any of the SF2/ASF-selected winners tested. More-
over, SRp40 inhibited splicing of the SF2/ASF-selected
winners even in the presence of SF2/ASF (data not
shown).
The SRp55 winner C1 spliced in S100 extract plus any
of the three SR proteins we examined. However, addi-
tion of two SR proteins did not increase its splicing
efficiency. All the six other SRp55 winners tested failed
to splice in S100 extract plus SF2/ASF or SRp40 (Ta-
ble 1).
Table 1. Summary of the activities and specificities of three
types of in vitro-selected ESEs
No SR
proteins SF2/ASF SRp40 SRp55
B1 − +++ ± ±
B2 − ++ ± +
B3 − +++ − −
B4 − +++ − ±
B5 − + ± ±
B6 − +++ ± ±
B7 − ++ ± ±
B8 − +++ N.D. N.D.
E1 − − +++ +++
E2 − − ++ +++
E3 − ± ++ +
E4 − − ++ ++
E5 − ± + ++
E6 − − +++ +++
E7 − − ++ ++
C1 − ++ ++ +++
C2 − − − +
C3 − ± − +++
C4 − − − +++
C5 − − − +
C6 − ± − ++
C7 − ± ± +++
C8 − N.D. N.D. ++
The in vitro-selected ESEs were tested for function as part of
IgM minigene pre-mRNAs in HeLa S100 extract alone, or in
S100 extract complemented with recombinant SF2/ASF, SRp40,
or SRp55. The sequences of the B, E, and C winner series are
given in Figs. 3A, 4, and 5. (N.D.) Not determined.
SR protein-specific exonic splicing enhancers
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SR proteins bind specifically to the ESEs
in nuclear extract
We have selected ESEs that respond specifically to indi-
vidual SR proteins under splicing conditions. Because
the selection was on the basis of function, it does not
necessarily follow that the SR proteins bind directly to
the cognate ESEs, although this is generally thought to
be the case for at least some natural enhancers (see Dis-
cussion). To determine whether SR proteins directly
contact the novel ESEs, we carried out UV cross-linking
experiments under splicing conditions in nuclear ex-
tract. We used radiolabeled RNA fragments comprising
the M2 exon with the different ESEs. Twenty femto-
moles of an M2 exon RNA comprising the SF2/ASF-se-
lected winner B1 (referred to as B1E) was incubated in the
presence of excess cold exon M2 RNA competitors with
different ESEs. The reaction mixtures were then irradi-
ated with UV light on ice, digested with RNases A and
T1 and analyzed by SDS-PAGE. B1E RNA cross-linked
primarily to 34- and 50-kD polypeptides (Fig. 8A, lane 1).
The 50-kD product is a nonspecific RNA-binding protein
that cross-links to a wide variety of RNAs (data not
shown), and is useful as an internal control for recovery
and loading. Addition of cold RNA competitors showed
that the 34-kD polypeptide bound to the B1E RNA with
the greatest specificity (lanes 2,3). Other competitors,
comprising an SRp55-selected ESE (lanes 4,5), an SRp40-
selected ESE (lanes 10,11), ESEs selected by other SR
proteins (lanes 8,9,12,13), or a sequence from the initial
random pool (lanes 6,7) failed to compete specifically
with B1E for binding to the 34-kD polypeptide (compare
the reduction in intensity of the 34-kD band relative to
that of the 50-kD band). A minor cross-linked product of
60 kD also decreased in intensity in the presence of the
B1E competitor (lane 3), but not in the presence of the
other competitors. This may represent an additional pro-
tein that interacts specifically with this ESE, or mul-
timerization of the 34-kD product through additional
RNA–protein or protein–protein cross-linking.
To confirm that the 34-kD polypeptide is SF2/ASF, we
carried out immunoprecipitations after UV cross-linking
and RNase digestion (Fig. 8B) (Sun et al. 1993). As ex-
pected, the 34-kD polypeptide was the major crosslinked
product immunoprecipitated by a monoclonal antibody
specific for SF2/ASF (lane 2) but not by a control mono-
clonal antibody (lane 3).
Similar UV cross-linking experiments were attempted
with SRp40- and SRp55-selected ESEs. Cross-linked pro-
Figure 7. SR protein specificity of in vitro-selected ESEs. (A)
SRp40-selected ESEs are inactive with SF2/ASF. Splicing was
carried out in HeLa S100 extract complemented with 20 pmoles
of SF2/ASF (lanes 1,4,7,10,13,16,19), 20 pmoles of SRp40 (lanes
2,5,8,11,14,17,20), or 20 pmoles of SF2/ASF plus 20 pmoles of
SRp40 (lanes 3,6,9,12,15,18,21). (B) SRp40-selected ESEs can
function in the presence of SRp55. Splicing was carried out in
S100 extract complemented with 20 pmoles of SRp55 (lanes
1,4,7,10,13,16), 20 pmoles of SRp40 (lanes 2,5,8,11,14,17), or 20
pmoles of SRp55 plus 20 pmoles of SRp40 (lanes 3,6,9,12,15,18).
Figure 8. Specific binding of SF2/ASF to
an SF2/ASF-selected ESE. (A) UV cross-
linking competition binding assay. Radio-
labeled exon M2 RNA (20 fmoles) compris-
ing the B1 winner sequence (B1E) was in-
cubated under splicing conditions in HeLa
nuclear extract. Subsequent UV cross-link-
ing and RNase digestion resulted in label
transfer predominantly to two proteins of
34 and 50 kD. The former, which binds spe-
cifically, is presumed to be SF2/ASF (see
below). Cold competitor RNAs containing
either the B1 winner insert, an SRp55-se-
lected insert (C4E), an SRp40-selected in-
sert (E7E), or other control sequence in-
serts, were present in excess, as indicated
above the autoradiograph. (Lane 1) No competitor; in the remaining lanes, the indicated competitors were present in 5-fold excess (even
lanes) or 50-fold excess (odd lanes) over the labeled B1E RNA. (B) Immunoprecipitation of SF2/ASF UV cross-linked to the B1E RNA.
UV cross-linking was carried out as in A, lane 1. A 5% equivalent of the input was loaded directly (lane 1). Parallel reactions were
incubated with a control antibody (lane 3), or with anti-SF2/ASF monoclonal antibody (lane 2), and the immunoprecipitates were
recovered in SDS gel loading buffer. In A and B, the samples were analyzed by SDS-PAGE and autoradiography.
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teins of ∼40 and 55 kD were detected by use of radiola-
beled exon M2 RNAs corresponding to the SRp40 winner
E7 (E7E), and the 55-kD protein also cross-linked to the
SRp55 winner C4 (C4E), although the background was
high (data not shown). Neither of these RNAs cross-
linked to proteins with the mobility of SF2/ASF. Cross-
linking to the 55-kD protein was competed by an excess
of cold C4E RNA, but not by B1E or E7E. Immunopre-
cipitation with a polyclonal antiserum that recognizes
both SRp40 and SRp55 (Du et al. 1997) selectively pre-
cipitated cross-linked proteins of the expected size (data
not shown). These results suggest that, similar to SF2/
ASF, SRp55 and SRp40 also interact directly with their
cognate in vitro-selected ESEs.
Sequences that fit the consensus for in vitro-selected
ESEs are present in natural exons and known ESEs
Sequences identified by SELEX procedures do not neces-
sarily correspond to functional elements that have
evolved in nature (Irvine et al. 1991). To evaluate the
biological significance of the novel ESE consensus se-
quences we identified, we analyzed their distribution in
known sequences of natural genes. We reasoned that if
the short consensus motifs derived from the in vitro-
selected ESEs are akin to natural ESEs, they should be
present with higher probability in regions corresponding
to known ESEs than elsewhere in the exons or in intron
sequences. The score matrices derived for each of the
three SR proteins tested were used to search genes or
exons with previously characterized ESEs. The resulting
scores were then plotted against the position along the
exons or genes (Fig. 9).
The natural sequence of the mouse IgM exon M2 was
analyzed first, since our ESEs were selected in the con-
text of this exon, after deletion of its natural ESE. Re-
markably, a high density of motifs with high-score
matches to the SF2/ASF and SRp40 consensus was found
within the 73-nucleotide natural ESE mapped previously
(Watakabe et al. 1993). In contrast, few matching se-
quences were found in the flanking regions of the exon,
and most of these had lower scores, correlating with the
lack of splicing upon deletion of the natural ESE. The
distribution of motifs with high-score matches to the
SRp55 ESE consensus did not correlate with the location
of the natural ESE. The SR protein specificity of the
natural M2 ESE was not known from previous work, but
we have determined that IgM minigene transcripts com-
prising the natural ESE can function in S100 extract
complemented with SF2/ASF, SRp40 or SRp55 (data not
shown). The high-score SF2/ASF and SRp40 motifs are
present in clusters, suggesting that multiple copies of
these motifs are particularly effective as ESEs, or provide
an optimal context. Indeed, multimerization of short re-
peats often results in increased ESE activity, both in
natural and synthetic enhancer elements (Tian and Ma-
niatis 1993; Tanaka et al. 1994; Tacke and Manley 1995).
We next analyzed the sequence of the last exon of the
bovine growth hormone (bGH) gene, which contains a
natural ESE previously mapped to a 115-nucleotide frag-
ment, that is required for splicing of the preceding intron
(Sun et al. 1993). The highest density of sequences
matching the SF2/ASF, SRp40, and SRp55 consensus
ESEs was found within the 115-nucleotide fragment cor-
responding to the natural ESE, compared to the rest of
the 302-nucleotide exon. The highest scores for each of
the three SR protein motifs were all found within the
fragment with natural enhancer activity. Although the
last intron of the bGH pre-mRNA does not splice in S100
extract in the presence of SR proteins, as it apparently
requires additional factors, the ESE in the last exon was
previously shown to bind SF2/ASF specifically, and this
SR protein also stimulated bGH splicing in nuclear ex-
tract (Sun et al. 1993).
The caldesmon pre-mRNA is alternatively spliced in a
tissue-specific manner (Humphrey et al. 1995). An alter-
native 58 splice site within the large exon 5 is used in
nonmuscle cells, which also exclude exon 6. In smooth
muscle, the entire exon 5 is included and spliced to exon
6. A 32-nucleotide repeat present in multiple copies
within the 38 portion of exon 5 functions as an ESE to
enhance usage of the upstream non-muscle-specific 58
splice site (Humphrey et al. 1995). Our sequence analysis
showed that SF2/ASF and SRp40 ESE consensus se-
quences are highly enriched within the 38 portion of
exon 5, whereas SRp55 consensus sequences are found
much more frequently upstream of the non-muscle-spe-
cific 58 splice site.
Female-specific alternative splicing of the Drosophila
dsx pre-mRNA involves six 13-nucleotide repeat ele-
ments (dsxRE) and a purine-rich element (PRE) (Tian and
Maniatis 1993; Lynch and Maniatis 1995). These cis-act-
ing elements are essential for splicing of a dsx pre-
mRNA in HeLa cell nuclear extract. UV cross-linking
analysis showed that the fourth and fifth dsxREs bind
specifically to the human SR protein 9G8, whereas the
PRE binds preferentially to SF2/ASF and probably other
SR proteins of similar size in HeLa nuclear extracts
(Lynch and Maniatis 1996). Consistent with these re-
sults, our sequence analysis did not reveal any high-score
motifs matching the SF2/ASF, SRp40, and SRp55 ESE
consensus sequences within the fourth and fifth dsxREs,
whereas high-score matches to the SF2/ASF ESE were
found within the PRE.
Finally, we also analyzed the sequences of character-
ized ESEs present in exon 5 of chicken cardiac troponin
T (Xu et al. 1993), in exon 3 of the Tat gene of equine
infectious anemia virus (Gontarek and Derse 1996), in
late pre-mRNAs of bovine papilloma virus type 1 (Zheng
et al. 1996), in exon ED-A of human fibronectin (Lav-
igueur et al. 1993; Caputi et al. 1994), and in the exon
downstream of the tat–rev intron of HIV-1 (Amendt et al.
1995; Staffa and Cochrane 1995). In all cases, the se-
quence analysis was consistent with the available data
on these natural ESEs and the binding of SR proteins,
when known (data not shown).
Next, we used the same score matrices to analyze the
distribution of high-score motifs in human exons versus
introns. A total of 570 intron-containing genes, corre-
sponding to 2634 exons (431 kb) and 2079 introns (1300
SR protein-specific exonic splicing enhancers
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kb), were extracted from the ALLSEQ data (Burset and
Guigo 1996) and analyzed. We searched all sequences
with a score equal to or greater than the mean score of
the selected winner pool for each SR protein. Remark-
ably, high-score motifs matching each of the three SR
protein ESE consensus sequences were found more fre-
quently in exons than in introns. For SF2/ASF, the den-
sity of high-score motifs was 4.3 per kilobase of exon and
2.9 per kilobase of intron; for SRp40, the corresponding
numbers were 7.9 per kilobase of exon and 6.8 per kilo-
base of intron; and for SRp55, they were 5.5 per kilobase
of exon and 4.9 per kilobase of intron. The higher density
of high-score motifs in exons than in introns is statisti-
cally significant because of the large database size, and the
P-values for these pairwise comparisons were all <10−10.
Discussion
We have developed a method to identify ESE elements
that can function specifically with individual SR pro-
teins. This goal was accomplished by use of SR protein-
deficient HeLa extracts complemented with individual
SR proteins, and a pool of pre-mRNAs derived from
mouse IgM, whose natural ESE in exon M2 was replaced
by a 20-nucleotide segment of random sequence. Se-
quence analysis revealed that the motifs identified by
the selection for function with SF2/ASF, SRp40, or
SRp55 tend to be clustered in regions corresponding to
known, natural ESEs, compared to other exon regions.
The initial randomized pool of IgM-derived substrates
consisted of 20 fmoles of pre-mRNA (∼1.2 × 1010 mol-
ecules), which is large enough to include all possible 16-
mers (∼4.3 × 109). The longest motif we identified was
the 7-nucleotide consensus selected by SF2/ASF, indi-
cating that the initial random pool had sufficient com-
plexity. In parallel SELEX experiments, we also em-
ployed a different RNA pool, in which only 14 positions
within the IgM M2 exon were randomized. Functional
Figure 9. Distribution of in vitro-selected ESE consensus sequences within exons comprising natural ESEs. Score matrices were built
for each class of in vitro-selected ESE, as described in Materials and Methods. The indicated natural exon sequences were searched with
each score matrix, and the resulting scores (y-axis) were plotted against the nucleotide positions for each exon (x axis). Note that the
x-axis scales are different in each case, because of the different exon sizes. Graphs are shown for mouse IgM exon M2, bovine growth
hormone 38 exon, Drosophila dsx female-specific exon, and chicken caldesmon exon 5. High score motif matches are shown by blue
(SF2/ASF), red (SRp40), and yellow (SRp55) vertical bars. For each SR protein, only the sequence matches with a score greater than that
of the lowest scoring winner sequence in Figs. 3–5 are shown. Note that there is no relation between the height of bars of different
colors. The green horizontal bars under the x axis indicate previously mapped ESEs or the dsx PRE. The black horizontal bars denote
the dsx repeat elements (dsxREs).
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ESEs were also selected out of that library (data not
shown), suggesting that the 20-mer library can poten-
tially encode most, if not all, natural ESEs, and that the
library size we used was adequate. The functional SELEX
procedure was performed for only three rounds. This was
deemed sufficient, as all the winner sequences tested
proved to be functional. Additional rounds of selection
would be expected to result in loss of consensus se-
quence information, as only the most efficiently spliced
RNAs would be recovered.
Our experiments confirm and extend two previous
studies that used functional selection from random pools
to identify novel ESEs. Tian and Kole (1995) randomized
a 20-nucleotide region within the context of a duplicated
exon in a model b-globin pre-mRNA. They selected se-
quences that promoted inclusion of the middle dupli-
cated exon in HeLa nuclear extract. The resulting ESEs
after five or seven selection cycles included both purine-
rich and nonpurine-rich motifs (Tian and Kole 1995). A
related approach was used by Coulter et al. (1997) to
identify ESEs that promote inclusion of the internal al-
ternative exon 5 of chicken cardiac troponin T. In this
case, the natural ESE was replaced by a 13-nucleotide
randomized segment, and the selection for splicing was
carried out by three rounds of transient transfection into
QT35 quail cells. The resulting ESEs included both pu-
rine-rich elements and a novel class of AC-rich elements
(ACEs; Coulter et al. 1997). These pioneering studies
could not readily identify the factors responsible for ESE
recognition—although SR proteins were obvious candi-
dates—because they relied on crude nuclear extracts or
cultured cells. In addition, the novel ESEs did not fall
into obvious consensus sequences, most likely because
they represent a complex collection of elements recog-
nized by several distinct factors. We improved this gen-
eral approach by performing the selections in extracts
dependent upon addition of individual SR proteins,
which allowed us to identify functional ESEs recognized
and activated by each SR protein, and therefore to derive
a corresponding consensus sequence. Our selections
were carried out in a different context from those in the
above two studies, which focused on inclusion of an op-
tional exon; we used the last exon of the IgM pre-mRNA,
which requires an enhancer for splicing of the last intron
(Watakabe et al. 1993).
Previous work also attempted to address the specific-
ity of SR proteins in ESE recognition by use of conven-
tional SELEX procedures based on selection for high-af-
finity binding (Tacke and Manley 1995; Shi et al. 1997;
Tacke et al. 1997). These studies gave very different re-
sults from our current results with some of the same
SR proteins but with selection cycles based on function.
First, the consensus sequences obtained by these two
approaches are very different. The SF2/ASF motifs de-
fined by binding (Tacke and Manley 1995; A. Hanamura,
I. Watakabe, and A.R. Krainer, unpubl.), which are pu-
rine-rich, appear to be a subgroup of those defined by
function, although they yield relatively low scores when
analyzed with our SF2/ASF score matrix. It should be
noted that a purine-rich composition is not sufficient for
function, but rather, specific sequences are required
(Tanaka et al. 1994; Ramchatesingh et al. 1995). Second,
many of the winner sequences obtained by binding pro-
tocols were not functional as ESEs. In contrast, among
the winner sequences obtained by our functional selec-
tion protocol, many were tested, and all of these were
functional ESEs. Third, the complexity of the winner
sequences identified by binding SELEX is much lower
than that of the ESEs identified by functional SELEX. As
a result, the consensus sequences obtained from the
binding selection are less degenerate than those we ob-
tained through functional selection. This may be attrib-
utable in part to the use of more selection/amplification
cycles in some of the binding SELEX experiments. In the
natural situation, exon sequences are obviously very di-
verse. Degenerate sequence specificity is probably essen-
tial for a limited number of SR proteins to be able to
recognize a very large number of ESE-containing exons
in different genes.
The different results obtained by binding selection and
functional selection protocols shed light on the mecha-
nisms of ESE function. The binding selection is based on
the affinity of RNA–protein interactions, and the itera-
tive protocol is designed to yield the binding sites with
the highest affinity for the protein of interest. However,
it appears that the best binding sites are not necessarily
the best functional sites, and, in some cases, a high af-
finity may preclude function. In addition, optimal inter-
actions between an SR protein and its cognate ESEs may
require other splicing components, as opposed to just the
purified protein. The binding protocol is carried out with
the purified protein, whereas the functional selection
protocol is carried out in the presence of all components
required for splicing. There are also technical reasons
why iterative binding protocols may not yield optimal
functional sites. The binding affinity and/or the speci-
ficity of the binding may be significantly affected by the
idiosyncrasies of the binding assay employed (Irvine et
al. 1991). Indeed, several of the SF2/ASF and SRp40 win-
ners identified by iterative binding failed to bind to the
cognate SR protein when analyzed by a different binding
assay (Tacke and Manley 1995; Tacke et al. 1997). An-
other contributing factor to the discrepancy between the
results obtained in binding and functional assays may be
that in at least some applications of the former, trun-
cated proteins lacking the RS domain were used (Tacke
and Manley 1995). Although the precise functions of the
RS domains are not completely understood, they appear
to be important for protein–protein and/or RNA–protein
interactions (Wu and Maniatis 1993; Tacke et al. 1997;
Xiao and Manley 1997). Thus, deletion of the RS domain
may affect the binding specificity, as may an incorrect or
incomplete phosphorylation state of the domain. In ad-
dition, the use of oligo-histidine or other tags in some
studies may also affect the binding specificity. In the
present study, we used unagged proteins expressed in
Escherichia coli. Although these proteins are not phos-
phorylated when isolated, they are very rapidly phos-
phorylated upon addition to nuclear or S100 extracts
(Hanamura et al. 1998). Finally, in the case of the differ-
SR protein-specific exonic splicing enhancers
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ent consensus sequences obtained previously for Dro-
sophila B52 (Shi et al. 1997) and in the present study for
human SRp55, the binding specificity may have diverged
considerably between arthropods and vertebrates. For ex-
ample, the enhancer complex formed on the PRE of the
Drosophila dsx pre-mRNA binds SRp55/B52 in Dro-
sophila Kc cell extracts, but does not appear to bind hu-
man SRp55 in HeLa cell extracts (Lynch and Maniatis
1996).
The specific recognition of ESEs by SR proteins is well
documented. Some examples include recognition of pu-
rine-rich ESEs in bovine growth hormone pre-mRNA by
SF2/ASF (Sun et al. 1993), in cardiac troponin T by
SRp40 and SRp55 (Ramchatesing et al. 1995), and in the
dsx pre-mRNA by one of the Drosophila SRp30 proteins
(Lynch and Maniatis 1996). Our data address the molecu-
lar basis of the redundancy and specificity of SR proteins.
The different consensus sequences of the three types of
in vitro-selected ESEs, and their different responses to
individual SR proteins provide an indication of the speci-
ficity of SR proteins in ESE recognition and function.
The consensus sequence of SF2/ASF-selected ESEs, SR-
SASGA, matches the sequence of most purine-rich ESEs
characterized to date. It is worthwhile to note that this
sequence is devoid of U residues. In the HPRT and IgM
genes, the presence of C residues within the purine-rich
ESEs was compatible with enhancer function, whereas
changing the C residues to U residues abolished their
enhancer activity (Tanaka et al. 1994). The SRp55-se-
lected winners also had a reduced U content, and we
suspect that a low U composition contributes to the in-
formation content that defines ESEs recognized by these
SR proteins.
The SRp40-selected ESEs share a relatively short con-
sensus sequence, ACDGS. They could be activated by
SRp55, but not by SF2/ASF. The fact that SRp55 could
activate SRp40-selected ESEs suggests that these two SR
proteins, which are closely related in domain structure,
unmodified molecular mass (31.2 kD for SRp40; 39.6 kD
for SRp55), and sequence (65% identity; Screaton et al.
1995), also have some functional overlap. It is unlikely
that the sequences selected by SRp40 fortuitously com-
prise a distinct SRp55 recognition site, but not an SF2/
ASF site, as all of the seven independent SRp40 ESEs
tested had similar properties. When the SF2/ASF score
matrix was used to search the seven examined SRp40-
selected ESEs, most of them had a score lower than the
minimum score of the SF2/ASF-selected ESEs, which
could explain why SRp40-selected ESEs were not acti-
vated by SF2/ASF. We do not know why E4, which had
a score higher than the average score of SF2/ASF-se-
lected ESEs, was not activated by SF2/ASF. However, it
is likely that the sequence context, for example, in the
form of negative elements or silencers, somehow pre-
vents activation of this motif by SF2/ASF. A related ob-
servation is the fact that SRp40 inhibited splicing of
some SF2/ASF-selected ESEs even in the presence of
SF2/ASF. This may be attributable to formation of in-
hibitory complexes with SRp40, such that SR proteins
may also participate in exonic silencer function, depend-
ing on the sequence context. An interesting implication
is that the variable expression levels of these antagonis-
tic SR proteins may determine the cell type-specific
function of certain ESEs.
We did not observe any cooperative effects among the
SR proteins tested. However, the fact that most of the
ESEs we identified gave higher splicing efficiencies in
nuclear extract than in S100 extract complemented with
SR proteins suggests that other SR proteins and/or addi-
tional splicing factors may be required for optimal ESE
recognition or function. With other substrates, such as
b-globin or certain natural ESE-dependent pre-mRNAs,
comparable splicing efficiencies can be obtained in the
two systems. A few natural or synthetic ESE-dependent
pre-mRNAs can only splice in the nuclear extract, ap-
parently because they require one or more unknown fac-
tors, distinct from SR proteins, that are also absent in the
S100 extract (Sun et al. 1993; Tacke and Manley 1995;
Tacke et al. 1997). If this is a property of the ESE, rather
than its context, this class of ESEs may not be well rep-
resented in the consensus sequences we derived. How-
ever, we did find high-score motif matches within one
such natural ESE, that of the bGH last exon (Fig. 9). The
ESEs we obtained were selected to function in S100 ex-
tract plus an SR protein, and hence, it is not surprising
that at least basal function could be observed in this
complementation system. However, maximal activity
appears to require one or more additional factors that
may be limiting in the S100 extract.
Many natural ESEs have been found in the last several
years. Most of these well-defined ESEs are purine rich,
although this nucleotide composition may reflect an ex-
perimental bias. First, many of the biochemical studies
were carried out in HeLa cell nuclear extract, in which
SF2/ASF, which prefers purine-rich sequences, may be
the most abundant SR protein. Second, purine-rich mo-
tifs may be easier to find by visual inspection which,
together with the precedent of known purine-rich ESEs,
makes them more likely to be studied further. We have
identified three new degenerate motifs, which are not
necessarily purine rich. Significantly, the SF2/ASF and
SRp40 motifs we defined occur more frequently (and
with higher scores) within exon segments corresponding
to known ESEs than elsewhere in the exons. All of the
motifs also occur more often in exons than in introns
and may thus contribute to defining exon–intron bound-
aries. These consensus sequences may be useful for the
prediction of natural ESEs in uncharacterized exons. Our
data also suggest that target sites for multiple SR pro-
teins are clustered within natural ESEs. This may ex-
plain why large deletions are often required to inactivate
natural ESEs. The SRp55 ESE consensus motif did not
always correlate with the location of natural ESEs. Inter-
estingly, in the caldesmon gene, SF2/ASF and SRp40
sites are enriched in the 38 portion of exon 5 that is
included in smooth muscle cells, whereas SRp55 sites
occur more frequently in the 58 portion of exon 5 that is
included in all cell types. Inclusion of the constitutively
spliced upstream segment of exon 5 may also require a
functional ESE, which we would predict, on the basis of
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the present data, to be SRp55-dependent. The differential
recognition of the alternative 58 splice sites associated
with the caldesmon exon 5 by different SR proteins may
be responsible for the proper developmental and tissue-
specific expression of caldesmon by alternative splicing.
Our results with just three of the nine known SR pro-
teins indicate that a highly diverse set of sequences can
function as SR protein-specific ESEs. In fact, of the more
than 1010 20-mers we tested in the context of the IgM
exon M2, a significant proportion contained functional
enhancers. Thus, of the RNA molecules from the unse-
lected library that remained at the completion of a splic-
ing reaction in nuclear extract, ∼20% were spliced (Fig.
2). Likewise, in the present study and in two previous
studies, about 10%–20% of random 20-mers or 13-mers
comprised sequences that could enhance splicing signifi-
cantly above background (Tian and Kole 1995; Coulter et
al. 1997; and data not shown). This level of degeneracy in
sequence-specific RNA recognition may be essential to
allow evolution of effective ESEs interspersed with open
reading frames that are constrained by the structure and
function of the encoded proteins. These findings imply
that many exons are likely to have multiple ESEs that
are to some extent redundant, but which may also func-
tion additively or allow fine tuning of tissue-specific or
developmentally regulated expression. On the other
hand, we suspect that splicing silencer elements, which
are less well understood, will prove to have similar com-
plexity. As a result, it is likely that many natural se-
quences that match the simple motifs identified in this
study will fail to function as ESEs unless they are placed
in an appropriate context.
Materials and methods
Preparation of HeLa cell extracts and recombinant
SR proteins
Nuclear and cytosolic S100 extracts were prepared from fresh
12-liter suspension cultures of HeLa cells, as described (Mayeda
and Krainer 1998a).
Expression and purification of the authentic form of the re-
combinant SR proteins SF2/ASF, SRp40 and SRp55, by use of
the expression vector pET9c (Novagen), were carried out as de-
scribed previously (Krainer et al. 1991; Screaton et al. 1995). The
integrity and purity of these recombinant SR proteins were
checked by SDS-PAGE and their specific activities were deter-
mined by in vitro splicing of b-globin pre-mRNA in S100 extract
(data not shown).
Randomization and selection
The SELEX procedure is outlined in Figure 1A. The sequence of
the wild-type IgM exon M2 is shown in Figure 1B. The plasmids
µM1-2 and µMD, which bear a mouse IgM minigene with or
without the natural enhancer, respectively (Watakabe et al.
1993), were a generous gift from Prof. Y. Shimura. The random-
ized substrate pool was constructed by overlap-extension PCR
(Horton et al. 1989; Tian and Kole 1995). Two sets of PCRs were
performed with µMD as template. The first PCR was carried out
with primers R and A. The second PCR used primers P and B.
The products from the two reactions were then combined and
further amplified with primers P and A. The resulting PCR
product was then used for in vitro transcription with SP6 RNA
polymerase to generate a radiolabeled pre-mRNA substrate
pool. The pool of spliced mRNAs generated by in vitro splicing
was excised from a urea–polyacrylamide gel, eluted in 0.5 M
ammonium acetate plus 0.1% SDS, reverse transcribed by use of
Superscript II RT (GIBCO-BRL), and amplified by PCR with
primers P and A. The amplified product was further amplified
with primers S and A. The PCR product was purified on a 2%
agarose gel and reassembled into the pre-mRNA template by
overlap-extension PCR for the next round of selection. The re-
verse transcription and PCR reactions were performed as sug-
gested by the vendors (GIBCO-BRL and Stratagene, respec-
tively). All of the PCRs were carried out with the high-fidelity
Pfu DNA polymerase. The primers were purchased from Op-
eron and were used at a concentration of 1 µM. After three
rounds of selection, the amplified spliced products were sub-
cloned into the vector PCR-Blunt (Stratagene) and sequenced by
use of a Dye Terminator Cycle Sequencing kit (Perkin-Elmer)
and an automated ABI 377 sequencer. The second and third
rounds of SELEX were performed in nuclear extract depleted of
total SR proteins by Mg2+ precipitation (Blencowe et al. 1994).
The sequences of the primers were as follows: Primer P,
58-ATTTAGGTGACACTATAGAATAC-38; primer A, 58-GCA-
GGTCGACTCTAGAAAGAAG-38; primer S, 58-GTGAAAT-
GACTCTCAGCAT-38; primer B, 58-ATGCTGAGAGTCATT-
TCAC-38; primer R, 58-GTGAAATGACTCTCAGCAT(N)20-
CTAGTAAACTTATTCTTACGTC-38.
Identification of consensus motifs
among the selected sequences
Functional selected sequences for each SR protein were aligned
by use of Gibbs sampler (Lawrence et al. 1993), with the as-
sumption that there is a common sequence motif of length L
present at least once in all of the sequences. Because Gibbs
sampler is a stochastic algorithm, for each fixed L, at least 10
different runs (with different random seeds) were carried out for
times sufficient to achieve convergence. A conservative value
for L was determined empirically by observing a sharp drop in
information per parameter (Lawrence et al. 1993) as L was in-
creased. To exclude the possibility that the predicted consensus
motif arose by chance, the information per parameter was also
compared to alignments of random sequences obtained by shuf-
fling the nucleotides within each sequence. The final alignment
was manually adjusted in a few cases, when better matches to
the consensus could be obtained by including a few flanking
nucleotides in the alignment.
Construction of a scoring matrix
First, a frequency matrix fi (a) was calculated from the align-
ment (i is the position of nucleotide a). Given a background
frequency for the set of sequences, p(a), the scoring matrix is
defined by the following formula:
si ~a! = log2
fi~a! + ep~a!
p~a!~1 + e!
where i = (1, 2, ..., L), a = (A, C, G, U), and e = 0.5 is the Bayesian
prior parameter (Lawrence et al. 1993).
A motif score is equal to the sum of the scores at each posi-
tion. Motifs may be ranked by their scores. The top three scores
in each sequence using all three different scoring matrices (SF2/
ASF, SRp40, and SRp55) were calculated and tabulated (data not
shown).
SR protein-specific exonic splicing enhancers
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The sequence scores were consistent semiquantitatively with
the gel intensity data when the sequence-scores for a given SR
protein were defined as follows: (1) The maximum score for
each selected sequence was calculated using the scoring matrix,
and the threshold was defined as the minimum of these scores;
and (2) The sequence score was defined as the number of
nonoverlapping motifs that have a score greater than or equal to
the threshold. This integer score correlated well with the cor-
responding gel intensity.
It should be noted that a motif scoring matrix may depend on
the pre-mRNA substrate and on the experimental parameters,
such as the concentration of SR protein.
In vitro splicing
In vitro splicing was performed as described previously (May-
eda and Krainer 1998b). Briefly, 20 fmoles of 32P-labeled,
7CH3GpppG-capped SP6 or T7 transcripts generated from PCR
products were incubated in 25-µl splicing reactions. The reac-
tions contained 4 µl of HeLa nuclear extract or 7 µl of S100
extract in buffer D. The MgCl2 concentration was 4.8 mM.
Twenty picomoles of the appropriate SR protein was used in
S100 complementation assays. After incubation at 30°C for 4
hr, the RNA was extracted and analyzed on 5.5% or 12% poly-
acrylamide denaturing gels, followed by autoradiography.
UV cross-linking
UV cross-linking experiments were carried out under splicing
conditions with or without a 5- to 50-fold molar excess of un-
labeled RNA competitor. Polyvinyl alcohol was omitted from
the cross-linking reactions. After a 30-min incubation at 30°C
the reactions were exposed to 254 nm UV light by use of a
Spectronics XL-1000 UV cross-linker at a setting of 1.8 J/cm2 on
ice. RNase A (10 µg) and RNase T1 (100 units) were added and
the reactions were incubated for 15 min at 37°C. The cross-
linked proteins were analyzed by SDS-PAGE on a 12% gel, fol-
lowed by autoradiography.
Immunoprecipitations
Immunoprecipitations were performed as described (Sun et al.
1993). The anti-SF2/ASF monoclonal antibody recognizes the
amino terminus of SF2/ASF and does not cross-react with other
human SR proteins (Hanamura et al. 1998). Polyclonal antise-
rum against SRp40 (anti-HRS/SRp40) was a generous gift from
Drs. K. Du and R. Taub (Du et al. 1997). The cross-linking
reactions were precleared after incubation with control antibod-
ies and 50 µl of protein A–agarose (1:1 suspension) in 500 µl of
IP buffer (50 mM Tris-HCl at pH 8.0, 150 mM NaCl, 0.05%
NP-40) for 2 hr at 4°C. An unrelated monoclonal antibody of the
same isotype was used for the SF2/ASF preclearing step and
rabbit preimmune serum was used for the SRp40 preclearing
step. After spinning in a microcentrifuge for 30 min at 4°C, the
supernatants were transferred to tubes containing the appropri-
ate antibody immobilized on protein A–agarose and rocked
overnight at 4°C. The bound material was recovered by cen-
trifugation, washed twice with 1 ml of IP buffer, eluted in 30 µl
of sample buffer [62.5 mM Tris-HCl at pH 6.8, 2% (wt/vol) SDS,
10% (vol/vol) glycerol, 5% (vol/vol) 2-mercaptoethanol], and
analyzed by SDS-PAGE and autoradiography.
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